{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:20:36Z","timestamp":1759962036006},"reference-count":33,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T00:00:00Z","timestamp":1233619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:p><jats:bold>Abstract\u2002<\/jats:bold> Clinical trial data rarely identify factors contributing to the placebo response. We reanalysed the data from the placebo arm (<jats:italic>n<\/jats:italic>\u2003=\u2003157) of a functional dyspepsia (FD) trial to determine predictors of placebo response including total GIS score, change in GIS score during run\u2010in, type of FD symptoms, duration of illness, age, gender, body mass index (BMI), family occurrence of FD\u2010like symptoms, smoking and alcohol consumption. The same response criteria were applied to the drug arm (<jats:italic>n<\/jats:italic>\u2003=\u2003158) of the study. Based on the initial 40% response criterion of the study, 35 (22.2%) were classified as placebo responders (PR), whilst 122 (78.8%) were placebo non\u2010responders (PnR). Response rates for the drug arm were 41.1 and 56.9% respectively. PR had significantly lower GIS scores compared to PnR at visit 1 (10.6\u2003\u00b1\u20030.6 and 12.3\u2003\u00b1\u20030.4, respectively, <jats:italic>P<\/jats:italic>\u2003=\u20030.035), but not at visit 2 with study medication dispensing (10.9\u2003\u00b1\u20030.5 and 11.3\u2003\u00b1\u20030.4). Hence, PR symptoms increased during run\u2010in by 4.2% whilst PnR symptoms decreased by 6.3% (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.005). Gender, age and duration and type of FD symptoms were not different between PR and PnR. Smoking was less prevalent in PR (3%) compared to PnR (21%) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.025). Increasing the criteria for the placebo response resulted in higher BMI for PR than for PnR (<jats:italic>P<\/jats:italic>\u2003=\u20030.035). None of the predictors for placebo response were able to distinguish responders from non\u2010responders to the drug. Variables predicting the PR point towards behavioural and biological mechanism of the PR, operating simultaneously and independently.<\/jats:p>","DOI":"10.1111\/j.1365-2982.2008.01241.x","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T12:12:13Z","timestamp":1233663133000},"page":"370-377","source":"Crossref","is-referenced-by-count":38,"title":["The placebo response in functional dyspepsia \u2013 reanalysis of trial data"],"prefix":"10.1111","volume":"21","author":[{"given":"P.","family":"Enck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Vinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Klosterhalfen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,11]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00676.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02938.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655201750305440"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178676"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.024"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.057"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00086-8"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30509.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2007.00937.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00650.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00626-3"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02845.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199329"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-872605"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03274-X"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.40948.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.4.430"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01183.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02572.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2007.11.007"},{"key":"e_1_2_5_22_2","first-page":"MS54","article-title":"Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries","volume":"11","author":"Fricchione G","year":"2005","journal-title":"Med Sci Monit"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2003.11.006"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31802eb4b7"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(03)00073-3"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.074518"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00485-7"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245861"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60159-7"},{"key":"e_1_2_5_30_2","article-title":"Gender and the nocebo response following conditioning and suggestion","author":"Enck P","journal-title":"J Psychosom Res"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.06.030"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528509089627"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.070789"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01166.x"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2008.01241.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2982.2008.01241.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:57:43Z","timestamp":1696967863000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2008.01241.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,11]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1365-2982.2008.01241.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2008.01241.x","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,11]]}}}